HHM Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.2K Buy
1,183
+83
+8% +$4.77K 0.01% 342
2026
Q1
$66.7K Sell
1,100
-110
-9% -$6.41K 0.01% 332
2025
Q4
$65.3K Sell
1,210
-268
-18% -$12.9K 0.01% 323
2025
Q3
$66.7K Sell
1,478
-466
-24% -$21.8K 0.01% 330
2025
Q2
$90K Sell
1,944
-667
-26% -$32.7K 0.01% 289
2025
Q1
$159K Sell
2,611
-255
-9% -$14.9K 0.02% 216
2024
Q4
$162K Buy
2,866
+514
+22% +$28.7K 0.02% 207
2024
Q3
$122K Sell
2,352
-666
-22% -$31.2K 0.02% 230
2024
Q2
$125K Buy
3,018
+1,052
+54% +$47.1K 0.02% 221
2024
Q1
$107K Sell
1,966
-158
-7% -$8.05K 0.02% 201
2023
Q4
$109K Sell
2,124
-275
-11% -$14.4K 0.02% 203
2023
Q3
$139K Buy
2,399
+205
+9% +$12.6K 0.03% 163
2023
Q2
$140K Buy
2,194
+650
+42% +$43.6K 0.03% 168
2023
Q1
$107K Buy
1,544
+368
+31% +$26K 0.02% 193
2022
Q4
$84.6K Hold
1,176
0.02% 189
2022
Q3
$84K Sell
1,176
-525
-31% -$38.1K 0.02% 177
2022
Q2
$131K Buy
1,701
+506
+42% +$38.5K 0.03% 169
2022
Q1
$87K Sell
1,195
-1,630
-58% -$109K 0.02% 234
2021
Q4
$176K Buy
2,825
+290
+11% +$17K 0.04% 149
2021
Q3
$150K Sell
2,535
-6
-0.2% -$395 0.04% 164
2021
Q2
$170K Hold
2,541
0.05% 153
2021
Q1
$160K Hold
2,541
0.05% 138
2020
Q4
$158K Hold
2,541
0.05% 118
2020
Q3
$153K Sell
2,541
-181
-7% -$10.9K 0.06% 105
2020
Q2
$160K Sell
2,722
-500
-16% -$29.9K 0.07% 96
2020
Q1
$180K Buy
+3,222
New +$197K 0.09% 82

Other funds holding BMY

HHM Wealth Advisors's BMY Position: Q2 2026 in Review

HHM Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 7.5% in Q2 2026, buying an estimated $4.77K and bringing the position to 1,183 shares worth $68.2K. The position accounts for 0.01% of the portfolio, ranked #342.

HHM Wealth Advisors first reported a position in BMY in Q1 2020 and has held it in 26 quarters since. The position peaked at $180K in Q1 2020. 800 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • HHM Wealth Advisors held 1,183 shares of Bristol-Myers Squibb worth $68.2K as of Q2 2026.
  • HHM Wealth Advisors bought 83 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.77K.
  • Bristol-Myers Squibb made up 0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #342 holding.
  • HHM Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 26 quarters since.
  • HHM Wealth Advisors's Bristol-Myers Squibb position peaked at $180K in Q1 2020.
  • 800 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.